D-Mannose 28 s

Dénomination commerciale

D-Mannose 28 s

D-072197NY

B-072197NY

Numéro de référence/catalogue

072197

EUDAMED

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

To prevent and support the treatment of urinary tract infections.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• G0499ORALLY ADMINISTERED GASTROINTESTINAL DEVICES - OTHER

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Warnings: • Do not use when allergic to any of the ingredients; • Adverse effects may occur in overdose, such as flatulence, stomach ache or diarrhoea; • Keep out of reach of young children; • If you experience allergic reactions, stop using Lucovital® D-Mannose sachets. Consult your doctor if: • you discover traces of blood in the urine; • symptoms worsen or persist after 7 days; • you have an existing medical condition or are taking other medication; • you have symptoms of bladder or upper urinary tract infection such as a fever of 38˚C (100.4F) or higher, noncontrollable shivering, nausea (feeling sick), vomiting or diarrhoea. You may suffer from an upper urinary tract infection, which needs additional treatment; • you have a history of kidney stones; • you take blood thinners. Use during pregnancy and/or breastfeeding: There is no data available concerning the use of D-mannose sachets during pregnancy or breastfeeding. Therefore you cannot use this product during pregnancy or breastfeeding. Side effect(s): Lucovital® D-Mannose sachets is well tolerated and has few side effects. Stomach upset or diarrhoea could be a side effect, but is very rare.